DelveInsight’s “Hyperopia Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Hyperopia, historical and forecasted epidemiology as well as the Hyperopia market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Hyperopia market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Hyperopia Market Forecast
Some of the key facts of the Hyperopia Market Report:
-
The Hyperopia market size was valued approximately ~USD 3200 million in 2023 and is anticipated to grow with a significant CAGR during the study period (2020-2034)
-
In January 2025, ZEISS Medical Technology announced that the MEL® 90 received FDA approval for myopia, hyperopia, and mixed astigmatism. The excimer laser integrates into the Corneal Refractive Workflow, providing U.S. surgeons with a fast, reliable, and streamlined surgery experience, complementing the VISUMAX® 800 with SMILE® pro to enhance refractive practices and improve patient outcomes.
-
Among the 7MM, the United States accounted for the highest market size i.e. approximately USD 1800 million in 2023, and is expected to grow during the forecast.
-
In the US, the overall prevalent cases of hyperopia surpassed 16 million in 2023, with projections indicating further growth in the forecast period.
-
According to the analysis, hyperopia was observed to be more prevalent among individuals aged 60–69 years in the US, constituting approximately 25% of the total cases.
-
At present, there are no authorized treatments available for hyperopia. Nevertheless, Vyluma is progressing with the development of a drug named NVK-033 intended for hyperopia treatment, currently in the clinical proof-of-principle phase.
-
Key Hyperopia Companies: Vyluma, Center For Excellence In Eye Care, Technolas Perfect Vision GmbH, and others
-
Key Hyperopia Therapies: NVK-033, ketorolac (Acular LS), Supracor, and others
-
The Hyperopia market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Hyperopia pipeline products will significantly revolutionize the Hyperopia market dynamics.
Hyperopia Overview
Hyperopia, commonly known as farsightedness, is a refractive error of the eye where distant objects can be seen more clearly than nearby objects. This occurs when the eyeball is shorter than normal or when the cornea has too little curvature.
Get a Free sample for the Hyperopia Market Forecast, Size & Share Analysis Report:
https://www.delveinsight.com/report-store/hyperopia-market
Hyperopia Epidemiology
The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.
Hyperopia Epidemiology Segmentation:
The Hyperopia market report proffers epidemiological analysis for the study period 2020–2034 in the 7MM segmented into:
-
Total Prevalence of Hyperopia
-
Prevalent Cases of Hyperopia by severity
-
Gender-specific Prevalence of Hyperopia
-
Diagnosed Cases of Episodic and Chronic Hyperopia
Download the report to understand which factors are driving Hyperopia epidemiology trends @ Hyperopia Epidemiology Forecast
Hyperopia Drugs Uptake and Pipeline Development Activities
The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Hyperopia market or expected to get launched during the study period. The analysis covers Hyperopia market uptake by drugs, patient uptake by therapies, and sales of each drug.
Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.
The report also covers the Hyperopia Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.
Hyperopia Therapies and Key Companies
-
NVK-033: Vyluma
-
ketorolac (Acular LS): Center For Excellence In Eye Care
-
Supracor: Technolas Perfect Vision GmbH
Discover more about therapies set to grab major Hyperopia market share @ Hyperopia Treatment Landscape
Scope of the Hyperopia Market Report
-
Study Period: 2020–2034
-
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
-
Key Hyperopia Companies: Vyluma, Center For Excellence In Eye Care, Technolas Perfect Vision GmbH, and others
-
Key Hyperopia Therapies: NVK-033, ketorolac (Acular LS), Supracor, and others
-
Hyperopia Therapeutic Assessment: Hyperopia current marketed and Hyperopia emerging therapies
-
Hyperopia Market Dynamics: Hyperopia market drivers and Hyperopia market barriers
-
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
-
Hyperopia Unmet Needs, KOL’s views, Analyst’s views, Hyperopia Market Access and Reimbursement
To know more about Hyperopia companies working in the treatment market, visit @ Hyperopia Clinical Trials and Therapeutic Assessment
Table of Contents
1. Hyperopia Market Report Introduction
2. Executive Summary for Hyperopia
3. SWOT analysis of Hyperopia
4. Hyperopia Patient Share (%) Overview at a Glance
5. Hyperopia Market Overview at a Glance
6. Hyperopia Disease Background and Overview
7. Hyperopia Epidemiology and Patient Population
8. Country-Specific Patient Population of Hyperopia
9. Hyperopia Current Treatment and Medical Practices
10. Hyperopia Unmet Needs
11. Hyperopia Emerging Therapies
12. Hyperopia Market Outlook
13. Country-Wise Hyperopia Market Analysis (2020–2034)
14. Hyperopia Market Access and Reimbursement of Therapies
15. Hyperopia Market Drivers
16. Hyperopia Market Barriers
17. Hyperopia Appendix
18. Hyperopia Report Methodology
19. DelveInsight Capabilities
20. Disclaimer
21. About DelveInsight
About DelveInsight
DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Gaurav Bora
Email:Send Email
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
